Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.


This white paper discusses the benefits of a combined safety services and technology model for drug sponsors to meet evolving drug safety and pharmacovigilance needs, and highlights the advantages of working with a vendor that leverages this model. It also introduces IQVIA's Integrated Safety Model as a flexible, globally scalable solution.
Download and learn how IQVIA can benefit your safety service and technology needs.
Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Harness the power of global human expertise combined with automation, artificial intelligence (AI) and machine learning (ML) to design, build and execute end-to-end safety solutions.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.